Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate‐photodynamic therapy
ConclusionsMAL‐PDT is safe and effective in patients with Gorlin syndrome. Utilization of these recommendations may improve efficacy and clearance rates in this population.
Source: Journal of the European Academy of Dermatology and Venereology - Category: Dermatology Authors: N. Basset‐Seguin, R. Bissonnette, C. Girard, M. Haedersdal, J.T. Lear, C. Paul, S. Piaserico Tags: Original Article Source Type: research
More News: Academies | Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Dermatology | Gorlin syndrome | Pain | Pain Management | Skin | Skin Cancer